Clinical Trial Update: Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated prophylactic antibiotic administration to reduce infection risk associated with bladder injections of onabotulinumtoxinA for overactiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence
• Urinary Incontinence Urge

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2024-01-02